-
Ablashi D, Chatlynne L, Cooper H, et al. 1999. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer, 81: 893-897.
doi: 10.1038/sj.bjc.6690782
-
Ablashi D V, Chatlynne L G, Whitman J E Jr, et al. 2002. Spectrum of Kaposi's sarcoma-associated herpes-virus, or human herpesvirus 8, diseases. Clin Microbiol Rev, 15: 439-464.
doi: 10.1128/CMR.15.3.439-464.2002
-
Albini A, Paglieri I, Orengo G, et al. 1997. The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS, 11: 713-721.
doi: 10.1097/00002030-199706000-00003
-
Aoki Y, Tosato G. 2003. Targeted inhibition of angio-genic factors in AIDS-related disorders. Curr Drug Targets Infect Disord, 3: 115-128.
doi: 10.2174/1568005033481222
-
Aoki Y, Tosato G. 2004. HIV-1 Tat enhances Kaposi sar-coma-associated herpesvirus (KSHV) infectivity. Blood, 104: 810-814.
doi: 10.1182/blood-2003-07-2533
-
Atkinson J, Edlin B R, Engels E A, et al. 2003. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis, 187: 974-981.
doi: 10.1086/jid.2003.187.issue-6
-
Bechtel J T, Liang Y, Hvidding J, et al. 2003. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol, 77: 6474-6481.
doi: 10.1128/JVI.77.11.6474-6481.2003
-
Beral V. 1991. Epidemiology of Kaposi's sarcoma. Cancer Surv, 10: 5-22.
-
Beral V, Peterman T A, Berkelman R L, et al. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet, 335: 123-128.
doi: 10.1016/0140-6736(90)90001-L
-
Blackbourn D J, Lennette E T, Ambroziak J, et al. 1998. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis, 177: 213-216.
doi: 10.1086/jid.1998.177.issue-1
-
Blackbourn D J, Osmond D, Levy J A, et al. 1999. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. J Infect Dis, 179: 237-239.
doi: 10.1086/jid.1999.179.issue-1
-
Borkovic S P, Schwartz R A. 1981. Kaposi's sarcoma presenting in the homosexual man --a new and striking phenomenon! Ariz Med, 38: 902-904.
-
Burysek L, Yeow W S, Lubyova B, et al. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol, 73: 7334-7342.
-
Cannon M J, Dollard S C, Black J B, et al. 2003. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS, 17: 215-222.
doi: 10.1097/00002030-200301240-00012
-
Carbone A, Gaidano G. 1997. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol, 97: 515-522.
doi: 10.1046/j.1365-2141.1997.00064.x
-
Caselli E, Menegazzi P, Bracci A, et al. 2001. Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR. J Gen Virol, 82: 1965-1970.
doi: 10.1099/0022-1317-82-8-1965
-
Caselli E, Galvan M, Santoni F, et al. 2003. Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection. J Gen Virol, 84: 1123-1131.
doi: 10.1099/vir.0.18799-0
-
Caselli E, Galvan M, Cassai E, et al. 2003. Transient expression of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication. Intervirology, 46: 141-149.
doi: 10.1159/000071454
-
Caselli E, Galvan M, Cassai E, et al. 2005. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reacti-vation in latently infected cells. Blood, 106: 2790-2797.
doi: 10.1182/blood-2005-04-1390
-
Cathomas G, McGandy C E, Terracciano L M, et al. 1996. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol, 49: 631-633.
doi: 10.1136/jcp.49.8.631
-
Cesarman E, Chang Y, Moore P S, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med, 332: 1186-1191.
doi: 10.1056/NEJM199505043321802
-
Cesarman E. 2002. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproli-ferative diseases. Recent Results Cancer Res, 159: 27-37.
doi: 10.1007/978-3-642-56352-2
-
Chang Y, Cesarman E, Pessin M S, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266: 1865-1869.
doi: 10.1126/science.7997879
-
Chatlynne L G, Ablashi D V. 1999. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol, 9: 175-185.
doi: 10.1006/scbi.1998.0089
-
Chatlynne L G, Lapps W, Handy M, et al. 1998. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immuno-deficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosor-bent assay. Blood, 92: 53-58.
-
Cheng E H, Nicholas J, Bellows D S, et al. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A, 94: 690-694.
doi: 10.1073/pnas.94.2.690
-
Child E S, Mann D J. 2001. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence. Oncogene, 20: 3311-3322.
doi: 10.1038/sj.onc.1204447
-
Couty J P, Geras-Raaka E, Weksler B B, et al. 2001. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J Biol Chem, 276: 33805-33811.
doi: 10.1074/jbc.M104631200
-
de-The G, Bestetti G, van Beveren M, et al. 1999. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst, 91: 1888-1889.
doi: 10.1093/jnci/91.21.1888
-
Dedicoat M, Newton R, Alkharsah K R, et al. 2004. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis, 190: 1068-1075.
doi: 10.1086/jid.2004.190.issue-6
-
Duus K M, Lentchitsky V, Wagenaar T, et al. 2004. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol, 78: 4074-4084.
doi: 10.1128/JVI.78.8.4074-4084.2004
-
Enbom M, Sheldon J, Lennette E, et al. 2000. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol, 62: 498-504.
doi: 10.1002/(ISSN)1096-9071
-
Engels E A, Sinclair M D, Biggar R J, et al. 2000. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer, 88: 1003-1008.
doi: 10.1002/(ISSN)1097-0215
-
Ensoli B, Sgadari C, Barillari G, et al. 2001. Biology of Kaposi's sarcoma. Eur J Cancer, 37: 1251-1269.
doi: 10.1016/S0959-8049(01)00121-6
-
Ensoli B, Sturzl M, Monini P. 2001. Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Adv Cancer Res, 81: 161-200.
doi: 10.1016/S0065-230X(01)81005-8
-
Field N, Low W, Daniels M, et al. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci, 116: 3721-3728.
doi: 10.1242/jcs.00691
-
Friborg J Jr, Kong W, Hottiger M O, et al. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature, 402: 889-894.
-
Friedman-Kien A E. 1981. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol, 5: 468-471.
doi: 10.1016/S0190-9622(81)80010-2
-
Gambus G, Bourboulia D, Esteve A, et al. 2001. Prevalence and distribution of HHV-8 in different subpopu-lations, with and without HIV infection, in Spain. AIDS, 15: 1167-1174.
doi: 10.1097/00002030-200106150-00012
-
Gao S J, Boshoff C, Jayachandra S, et al. 1997. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene, 15: 1979-1985.
doi: 10.1038/sj.onc.1201571
-
Gao S J, Kingsley L, Li M, et al. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med, 2: 925-928.
doi: 10.1038/nm0896-925
-
Gessain A, Mauclere P, van Beveren M, et al. 1999. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer, 81: 189-192.
doi: 10.1002/(ISSN)1097-0215
-
Giraldo G, Beth E, Haguenau F. 1972. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst, 49: 1509-1526.
doi: 10.1093/jnci/49.6.1509
-
Goedert J J, Cote T R, Virgo P, et al. 1998. Spectrum of AIDS-associated malignant disorders. Lancet, 351: 1833-1839.
doi: 10.1016/S0140-6736(97)09028-4
-
Gottlieb G J, Ragaz A, Vogel J V, et al. 1981. A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men. Am J Dermatopathol, 3: 111-114.
doi: 10.1097/00000372-198100320-00002
-
Grossman Z, Iscovich J, Schwartz F, et al. 2002. Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc, 77: 905-909.
doi: 10.1016/S0025-6196(11)62256-8
-
Guasparri I, Keller S A, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med, 199: 993-1003.
doi: 10.1084/jem.20031467
-
Guo H G, Pati S, Sadowska M, et al. 2004. Tumorigenesis by human herpesvirus 8 vGPCR is accele-rated by human immunodeficiency virus type 1 Tat. J Virol, 78: 9336-9342.
doi: 10.1128/JVI.78.17.9336-9342.2004
-
Gwack Y, Hwang S, Byun H, et al. 2001. Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol, 75: 6245-6248.
doi: 10.1128/JVI.75.13.6245-6248.2001
-
Hengge U R, Ruzicka T, Tyring S K, et al. 2002. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis, 2: 344-352.
doi: 10.1016/S1473-3099(02)00288-8
-
Hideshima T, Chauhan D, Teoh G, et al. 2000. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res, 6: 1180-1189.
-
Huang L M, Chao M F, Chen M Y, et al. 2001. Reciprocal regulatory interaction between human herpes-virus 8 and human immunodeficiency virus type 1. J Biol Chem, 276: 13427-13432.
doi: 10.1074/jbc.M011314200
-
Hymes K B, Cheung T, Greene J B, et al. 1981. Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet, 2: 598-600.
-
Hyun T S, Subramanian C, Cotter M A 2nd, et al. 2001. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodefi-ciency virus type 1 in human cells. J Virol, 75: 8761-8771.
doi: 10.1128/JVI.75.18.8761-8771.2001
-
Iscovich J, Boffetta P, Franceschi S, et al. 2000. Classic kaposi sarcoma: epidemiology and risk factors. Cancer, 88: 500-517.
doi: 10.1002/(ISSN)1097-0142
-
Jacobson L P, Jenkins F J, Springer G, et al. 2000. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis, 181: 1940-1949.
doi: 10.1086/jid.2000.181.issue-6
-
Juhasz A, Remenyik E, Konya J, et al. 2001. Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors. J Med Virol, 64: 526-530.
doi: 10.1002/jmv.1081
-
Juhasz I, Albelda S M, Elder D E, et al. 1993. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol, 143: 528-537.
-
Kaaya S F, Leshabari M T, Mbwambo J K. 1998. Risk behaviors and vulnerability to HIV infection among Tanzanian youth. J Health Popul Dev Ctries, 1: 51-60.
-
Kaposi M. 1872. Idiopathisches multiples Pigmentsarkom der Haut.Arch Dermatol Syph, 4: 265-273.
doi: 10.1007/BF01830024
-
Kirchhoff S, Sebens T, Baumann S, et al. 2002. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J Immunol, 168: 1226-1234.
doi: 10.4049/jimmunol.168.3.1226
-
Lang M E, Lottersberger C, Roth B, et al. 1997. Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. AIDS, 11: 1333-1340.
-
Lennette E T, Blackbourn D J, Levy J A. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet, 348: 858-861.
doi: 10.1016/S0140-6736(96)03240-0
-
Li M, Lee H, Yoon D W, et al. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol, 71: 1984-1991.
-
Liu L, Eby M T, Rathore N, et al. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem, 277: 13745-13751.
doi: 10.1074/jbc.M110480200
-
Lubyova B, Pitha P M. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol, 74: 8194-8201.
doi: 10.1128/JVI.74.17.8194-8201.2000
-
Martin J N, Ganem D E, Osmond D H, et al. 1998. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med, 338: 948-954.
doi: 10.1056/NEJM199804023381403
-
Martin R W 3rd, Hood A F, Farmer E R. 1993. Kaposi sarcoma. Medicine (Baltimore), 72: 245-261.
doi: 10.1097/00005792-199307000-00004
-
Matta H, Chaudhary P M. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A, 101: 9399-9404.
doi: 10.1073/pnas.0308016101
-
Mayama S, Cuevas L E, Sheldon J, et al. 1998. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer, 77: 817-820.
doi: 10.1002/(ISSN)1097-0215
-
Mbulaiteye S M, Biggar R J, Goedert J J, et al. 2003. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr, 32: 527-533.
doi: 10.1097/00126334-200304150-00010
-
Mbulaiteye S M, Pfeiffer R M, Whitby D, et al. 2003. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis, 187: 1780-1785.
doi: 10.1086/jid.2003.187.issue-11
-
Mendez J C, Procop G W, Espy M J, et al. 1999. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation. Transplantation, 67: 1200-1201.
doi: 10.1097/00007890-199904270-00022
-
Merat R, Amara A, Lebbe C, et al. 2002. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reacti-vation. Int J Cancer, 97: 791-795.
doi: 10.1002/(ISSN)1097-0215
-
Mercader M, Taddeo B, Panella J R, et al. 2000. Induction of HHV-8 lytic cycle replication by inflam-matory cytokines produced by HIV-1-infected T cells. Am J Pathol, 156: 1961-1971.
doi: 10.1016/S0002-9440(10)65069-9
-
Mercader M, Nickoloff B J, Foreman K E. 2001. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8. Arch Pathol Lab Med, 125: 785-789.
-
Molden J, Chang Y, You Y, et al. 1997. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem, 272: 19625-19631.
doi: 10.1074/jbc.272.31.19625
-
Montaner S, Sodhi A, Pece S, et al. 2001. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res, 61: 2641-2648.
-
Moore P S, Chang Y. 2001. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci, 356: 499-516.
doi: 10.1098/rstb.2000.0777
-
Moore P S, Kingsley L A, Holmberg S D, et al. 1996. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS, 10: 175-180.
doi: 10.1097/00002030-199602000-00007
-
Moore P S, Gao S J, Dominguez G, et al. 1996. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol, 70: 549-558.
-
Munshi N, Ganju R K, Avraham S, et al. 1999. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. J Biol Chem, 274: 31863-31867.
doi: 10.1074/jbc.274.45.31863
-
Nador R G, Cesarman E, Chadburn A, et al. 1996. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood, 88: 645-656.
-
Nakamura H, Li M, Zarycki J, et al. 2001. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol, 75: 7572-7582.
doi: 10.1128/JVI.75.16.7572-7582.2001
-
Neipel F, Albrecht J C, Fleckenstein B. 1997. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol, 71: 4187-4192.
-
O'Brien T R, Kedes D, Ganem D, et al. 1999. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis, 180: 1010-1017.
doi: 10.1086/jid.1999.180.issue-4
-
Oettle A G. 1962. Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environ-mental or genetic causes. Acta Unio Int Contra Cancrum, 18: 330-363.
-
Olsen S J, Chang Y, Moore P S, et al. 1998. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS, 12: 1921-1925.
doi: 10.1097/00002030-199814000-00024
-
Osborne J, Moore P S, Chang Y. 1999. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling path-ways. Hum Immunol, 60: 921-927.
doi: 10.1016/S0198-8859(99)00083-X
-
Pati S, Cavrois M, Guo H G, et al. 2001. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol, 75: 8660-8673.
doi: 10.1128/JVI.75.18.8660-8673.2001
-
Pauk J, Huang M L, Brodie S J, et al. 2000. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med, 343: 1369-1377.
doi: 10.1056/NEJM200011093431904
-
Plancoulaine S, Abel L, van Beveren M, et al. 2000. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet, 356: 1062-1065.
doi: 10.1016/S0140-6736(00)02729-X
-
Plancoulaine S, Abel L, Tregouet D, et al. 2004. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res, 64: 8782-8787.
doi: 10.1158/0008-5472.CAN-04-2000
-
Preiser W, Szep N I, Lang D, et al. 2001. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems. Med Microbiol Immunol, 190: 121-127.
-
Rabkin C S, Janz S, Lash A, et al. 1997. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med, 336: 988-993.
doi: 10.1056/NEJM199704033361403
-
Radkov S A, Kellam P, Boshoff C. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med, 6: 1121-1127.
doi: 10.1038/80459
-
Regamey N, Cathomas G, Schwager M, et al. 1998. High human herpesvirus 8 seroprevalence in the homose-xual population in Switzerland. J Clin Microbiol, 36: 1784-1786.
-
Renne R, Blackbourn D, Whitby D, et al. 1998. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol, 72: 5182-5188.
-
Renne R, Lagunoff M, Zhong W, et al. 1996. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol, 70: 8151-8154.
-
Rivas C, Thlick A E, Parravicini C, et al. 2001. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol, 75: 429-438.
doi: 10.1128/JVI.75.1.429-438.2001
-
Russo J J, Bohenzky R A, Chien M C, et al. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A, 93: 14862-14867.
doi: 10.1073/pnas.93.25.14862
-
Samaniego F, Young D, Grimes C, et al. 2002. Vascular endothelial growth factor and Kaposi's sarcoma cells in human skin grafts. Cell Growth Differ, 13: 387-395.
-
Sarek G, Jarviluoma A, Ojala P M. 2006. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lym-phomas. Blood, 107: 725-732.
doi: 10.1182/blood-2005-06-2534
-
Sarid R, Flore O, Bohenzky R A, et al. 1998. Transcri-ption mapping of the Kaposi's sarcoma-associated herpes-virus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol, 72: 1005-1012.
-
Sarid R, Sato T, Bohenzky R A, et al. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med, 3: 293-298.
doi: 10.1038/nm0397-293
-
Schulz T F. 2000. KSHV (HHV8) infection. J Infect, 41: 125-129.
doi: 10.1053/jinf.2000.0712
-
Schwarz M, Murphy P M. 2001. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor cons-titutively activates NF-kappa B and induces proinflam-matory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol, 167: 505-513.
doi: 10.4049/jimmunol.167.1.505
-
Seo T, Lee D, Shim Y S, et al. 2002. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpes-virus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death. J Virol, 76: 8797-8807.
doi: 10.1128/JVI.76.17.8797-8807.2002
-
Seo T, Park J, Lee D, et al. 2001. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol, 75: 6193-6198.
doi: 10.1128/JVI.75.13.6193-6198.2001
-
Shin Y C, Nakamura H, Liang X, et al. 2006. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol, 80: 2257-2266.
doi: 10.1128/JVI.80.5.2257-2266.2006
-
Siegal F P, Lopez C, Hammer G S, et al. 1981. Severe acquired immunodeficiency in male homosexuals, mani-fested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med, 305: 1439-1444.
doi: 10.1056/NEJM198112103052403
-
Sitas F, Carrara H, Beral V, et al. 1999. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med, 340: 1863-1871.
doi: 10.1056/NEJM199906173402403
-
Smit M J, Verzijl D, Casarosa P, et al. 2002. Kaposi's sarcoma-associated herpesvirus-encoded G protein-cou-pled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J Virol, 76: 1744-1752.
doi: 10.1128/JVI.76.4.1744-1752.2002
-
Soulier J, Grollet L, Oksenhendler E, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA se-quences in multicentric Castleman's disease. Blood, 86: 1276-1280.
-
Sternbach G, Varon J. 1995. Moritz Kaposi: idiopathic pigmented sarcoma of the skin. J Emerg Med, 13: 671-674.
doi: 10.1016/0736-4679(95)00077-N
-
Sturzl M, Hohenadl C, Zietz C, et al. 1999. Expression of K13/v-FLIP gene of human herpesvirus 8 and apo-ptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst, 91: 1725-1733.
doi: 10.1093/jnci/91.20.1725
-
Sun Q, Matta H, Chaudhary P M. 2005. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB path-way and functionally cooperates with Tat. Retrovirology, 2: 9.
doi: 10.1186/1742-4690-2-9
-
Wan X, Wang H, Nicholas J. 1999. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol, 73: 8268-8278.
-
West J T, Wood C. 2003. The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expres-sion.Oncogene, 22: 5150-5163.
doi: 10.1038/sj.onc.1206555
-
Whitby D, Howard M R, Tenant-Flowers M, et al. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet, 346: 799-802.
doi: 10.1016/S0140-6736(95)91619-9
-
Whitby D, Luppi M, Barozzi P, et al. 1998. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst, 90: 395-397.
doi: 10.1093/jnci/90.5.395
-
Zeng Y, Zhang X, Huang Z, et al. 2007. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol, 81: 2401-2417.
doi: 10.1128/JVI.02024-06
-
Zhu F X, Chong J M, Wu L, et al. 2005. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol, 79: 800-811.
doi: 10.1128/JVI.79.2.800-811.2005
-
Ziegler J L, Newton R, Katongole-Mbidde E, et al. 1997. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS, 11: 1619-1626.
doi: 10.1097/00002030-199713000-00011